MedPath

Biomarkers for Intestinal Permeability

Completed
Conditions
Focus: Simplified Method to Assess Intestinal Permeability
Registration Number
NCT04667208
Lead Sponsor
University of Hohenheim
Brief Summary

This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate markers for effortful "gold standard" methods.

Detailed Description

This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate markers for effortful "gold standard" methods. In healthy volunteers potential biomarkers for intestinal permeability as well as an established "gold standard" method for intestinal permeability (urinary lactulose/mannitol excretion) will be measured at one time point. Using correlation analyses, potential associations will be assessed and potential biomarkers will be addressed and discussed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Healthy volunteers
  • Written informed consent
Exclusion Criteria
  • Underweight (BMI <18 kg / m2) and obesity from grade II (BMI ≥ 30 kg / m2)
  • Acute or chronic gastrointestinal diseases
  • Chronically consuming diseases (e.g. chronic tumor disease, florid infections, etc.)
  • Smokers (12 hours before the test and during the test it is not allowed to smoke)
  • Ingestion of intestinal therapeutics, antibiotics, immunosuppressants or similar within the last 3 months
  • Simultaneous participation in another clinical study
  • Pregnancy / breastfeeding
  • Intolerance to the sugar solution
  • Occurrence of relevant diseases
  • Revocation of consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lactulose / mannitol ratio1 day (Single measurement)

Urinary excretion of lactulose and mannitol

Secondary Outcome Measures
NameTimeMethod
Fecal albumin [ng/mg]1 day (Single measurement)

Potential easy-to-measure biomarker #1

Fecal calprotectin [ng/mg]1 day (Single measurement)

Potential easy-to-measure biomarker #2

Fecal zonulin [ng/mg]1 day (Single measurement)

Potential easy-to-measure biomarker #3

Plasma lipopolysaccharide binding protein [µg/ml]1 day (Single measurement)

Potential easy-to-measure biomarker #4

Trial Locations

Locations (1)

University of Hohenheim

🇩🇪

Stuttgart, Germany

© Copyright 2025. All Rights Reserved by MedPath